Table 2.

Odds ratio (left side) and median titers (right side) of anti-dsDNA, anti-Sm and anti-RibP autoantibodies in relation to SLE clinical manifestations included in SLEDAI-2K. Of 192 SLE patients, 33 presented clinical manifestations. Six of them presented two manifestations concurrently: 4 mucocutaneous and musculoskeletal, 1 renal and haematological, and 1 musculoskeletal and haematological. Neurological and serosal manifestations are not present in our cohort. The statistically significant results are indicated in bold typeface.